Funding Details
- Awarder
- Inbox
- Date Award
- December 18, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Founding Year
- 2010
- Traction
- SiteOne has received significant investment after years of small grant funding, indicating renewed interest in their approach to pain management.
- Founders
- John Mulcahy
- Company Description
- SiteOne Therapeutics is focused on developing non-addictive pain drugs by targeting ion channels in peripheral nerve cells. The company aims to obtain proof of concept for its medicines through human studies.
- Market
- Non-opioid pain medications
- Location
-
USA
- Coinvestors
- Novo Holdings, OrbiMed, Wellington Management, Mission BioCapital, BSquared Capital
Links